B. Stefanini

Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.

A. Gasbarrini, V. Santi, G. Svegliati-Baroni, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, Liver Cancer International.

Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

A. Gasbarrini, F. Piscaglia, V. Santi, 2023, JHEP reports : innovation in hepatology.

Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.

G. Rapaccini, C. Campani, A. Masotto, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.